|
|
||||||||
1 From the Département de Physiologie (Equipe dAccueil 2689 & Institut Fédératif de Recherche 22), Université Lille Il; 2 Exploration Fonctionnelle de la Vision, CHR&U Lille; 3 Clinique Neurologique, CHR&U Lille, France.
| Abstract |
|---|
|
|
|---|
METHODS. Clinical study: The standing ocular potential was recorded during intravenous (IV) infusion of glucose 5% and glucose 5% + prednisolone 0.2% in 14 patients with relapsing multiple sclerosis. The results were compared with a control group receiving two successive identical glucose 5% infusions. In vitro study: Native tissue explants (RPE + choroid, porcine, and bovine) were placed in a Ussing-type chamber. After baseline determination of the transepithelial potential (PD), short circuit current (Isc) and transepithelial resistance (Rt), the effect of apical hydrocortisone (HC) 10-4 M was determined.
RESULTS. Clinical study: A significant rise of the standing potential was found after glucose infusion (P = 0.005), whereas no change was detected after IV glucose + prednisolone (P = 0.695). In vitro study: In the porcine RPE, the mean baseline PD and Isc were significantly reduced (both P = 0.012) after applying apical 10-4 HC. Rt was also significantly reduced (P = 0.01). The same type of response, observed in bovine RPE, was reduced in low chloride/low bicarbonate conditions.
CONCLUSIONS. Corticosteroids modified electrophysiological parameters representing RPE function in vivo. The existence of an RPE-specific effect was confirmed in vitro. Further work is required to link the observed ion transport changes to a reduction of apical, subretinal fluid absorption.
| Introduction |
|---|
|
|
|---|
Currently, there is some evidence for pathophysiological links between corticosteroid treatment and the incidence of central serous chorioretinopathy.3 4 5 6 The existence of this hypothesized effect at the RPE level has never been demonstrated clearly. Fluid transport changes across an intact RPE are related to transepithelial ion flux, which necessarily induce measurable electrophysiological changes. The purpose of this study was to demonstrate the existence of RPE-related electrophysiological effects of corticosteroids in vivo and in vitro.
| Materials and Methods |
|---|
|
|
|---|
In a preliminary study, the standing ocular potential was recorded in the group of 14 healthy controls. Skin electrodes were placed in accordance with ISCEV guidelines to perform electro-oculography.7 The subject was placed in Ganzfeld conditions at a luminance of 60 cd/m2 for 10 minutes. Then the recording procedure started. Every 2 minutes, during a 58-minute period, the standing potential of the eye was recorded as the subject performed target-triggered saccades. The analysis of the mean standing potential of the right eye revealed a slow oscillation response with a mean periodicity of 34 minutes (Fig. 1) . The first trough occurred at 12 minutes, the second at 46 minutes. The shift between the minimum (trough) to the maximum amplitude (peak) was determined. This shift was found to be statistically significant (Table 1) .
|
|
The first group of consecutive patients was assigned to the prednisolone group. They first received (at t = 11 minutes) an intravenous infusion of glucose 5% and then (at t = 45 minutes) an intravenous infusion of glucose 5% and prednisolone 0.2%. It was estimated that the plasma level of 100 µM was obtained within 10 minutes.8 The second group of patients was assigned to the glucose group, in which only two successive infusions of glucose 5% were compared, and no prednisolone was added to the second infusion.
Results are shown as means ± SD. Only the recording of the right eye of each patient was analyzed. Comparisons of paired sets of data (trough to peak shift) within each group of subjects (phase 1 versus phase 2) were made using a Wilcoxon rank test. Comparisons of unpaired sets of data (trough-to-peak shift) between the different groups of subjects (phase 1: glucose versus prednisolone, phase 2: glucose versus prednisolone) were made using a MannWhitney U test. For both series of tests, P < 0.05 was considered significant.
In Vitro Tissue Study
The research followed the tenets of the ARVO Statement for the Use of
Animals in Ophthalmic and Vision Research. Large white pigs were
enucleated after premedication with intramuscular ketamine and general
anesthesia with pentobarbital. Bovine eyes were provided by a local
slaughterhouse. The eyes were transferred to phosphate-buffered saline
(composition in mM/l: NaCl 140, KCl 4, Na2HPO4
0.5, KH2PO4 0.15 [pH 7.4]).
The eyes were opened posterior to the limbus (3 mm in porcine eyes, 6 mm in bovine eyes) with a surgical blade, then cut on the entire circumference with surgical scissors. The choroid was separated form the sclera by blunt dissection. The retina was then gently removed from the underlying RPE.
The native tissue (pigment epithelium + choroid) was placed between two
half-Ussingtype chambers within 4 hours after enucleation. A 0.163
cm2 area of the tissue sample was exposed to 10 ml of
solution on each side (apical side = retina and basolateral
side = choroid) and gassed with 12% O25%
CO2%83% N2, as low oxygen increases
longevity of RPE function.9
The experiments were conducted
at 37°C. The short-circuit current (Isc) was monitored
continuously using a DVC 1000 voltage clamp (WPI, Aston, UK), and the
potential difference (PD) was measured every 2 minutes. Voltage-sensing
electrodes and the current passing bridges consisted of 3 M KCl-agar;
the reference electrodes were placed at the basolateral side.
Transepithelial resistance (Rt) was determined by clamping
the PD to +10 mV at 15-second intervals, recording the deflection of
Isc, and applying Ohms law. The preparations were allowed
to equilibrate. Stabilization of bioelectrical parameters was achieved
within 30 to 40 minutes. Only tissue samples with an Rt > 80
· cm2 were considered for analysis. Basal
bioelectrical activity was monitored for 15 minutes before the addition
of the reagents. Hydrocortisone (10-4) was
dissolved in the KBR solution (vehicle) and added to the apical or the
basolateral bath. This concentration was chosen in accordance with the
estimated plasma and vitreous levels in the clinical part of this
study.8
10
Changes in PD, Isc, and
Rt were calculated as the variation between the values
measured immediately before the addition of reagents and the values
corresponding to the peak phase.
KrebsRinger bicarbonate buffer (KRB) had the following composition (in mM/l): 140 Na, 120 Cl, 5.2 K, 1.2 Mg, 1.2 Ca, 2.4 HPO4, 0.4 H2PO4, 25 HCO3, 5.5 glucose, and 1.0 glutathione (pH 7.3).
Cl-free solution was obtained by replacing NaCl and KCl by Na and K gluconate salts. In the bicarbonate-free solution, NaHCO3 was replaced with NaGluconate.
Results are expressed as means ± SD for each set of preparations. Comparisons of paired sets of data (PD, Isc, Rt, respectively before and after addition of HC) were made using a Wilcoxon rank test.
Comparisons of unpaired sets of data (PD, Isc, Rt) corresponding to different bath solutions (KRB versus Cl-free solution, Cl-free solution versus Cl-free solution + bumetanide, Cl-free solution versus Cl-freeHCO3-free solution) were made using a MannWhitney U test. For both series of tests, P < 0.05 was considered significant.
| Results |
|---|
|
|
|---|
|
The following 14 patients were included in the glucose group. No significant difference of the standing potential of the eye could be found between the two recording sessions (Fig. 3) . The peak to trough shift was found to be statistically significant in both sessions (phase 1 and phase 2); it was slightly higher after the second glucose infusion, however this difference did not reach statistical significance (Table 1) .
|
Bovine In Vitro Study
In the bovine RPE, Table 2
summarizes the effects of HC in KRB, in low chloride and low
chloride-low bicarbonate solutions. Apical 10-4
HC reduced the transepithelial potential, the short circuit current,
and the transepithelial resistance in the KRB bath. When using the low
chloride solution, the HC-mediated reduction of PD,
Isc, and Rt appeared to be
inhibited, although not completely blocked. Adding apical bumetanide
10-4, a selective inhibitor of transepithelial
chloride flux, to the low chloride bath, did not significantly modify
the hydrocortisone response, when comparing it with the response
observed in low chloride solutions without bumetanide. In a
bicarbonate-freelow chloride bath, the response to hydrocortisone
appeared to be completely blocked.
|
| Discussion |
|---|
|
|
|---|
The electro-oculogram (EOG) is known to be one of the most appropriate ways of studying the function of human RPE,7 which compares the light response to the dark trough after dark adaptation. However, the light response is thought to be generated by the interaction of retina and RPE, which seems to be essentially linked to increased basolateral Cl conductance.11 Only the standing potential recorded at constant luminance conditions can be considered to be representative of RPE function. For this reason, the authors chose to develop an original protocol of EOG recording. It established that corticosteroids could induce changes of the standing potential when compared with controls. However, the hypothesized RPE-related origin of this EOG finding remained to be confirmed by in vitro recordings.
HC was found to modify the electrical parameters of the bovine RPE. A marked decrease of PD and Isc was observed after administration of HC on the apical side of the bovine RPE. No such response was observed on the basolateral side of the preparation. Certain transport mechanisms of the bovine RPE appear to be species-dependent, yet a similar response to HC in tapetum-free porcine RPEchoroid explants confirmed these findings in the present study, in conditions that might be functionally closer to human RPE. However, the experienced firm adherence between choroid and sclera made blunt dissection more difficult, thus probably altering the electrical properties of the tissue explant. This might explain the low potential difference obtained in the current porcine study, compared with bovine RPE, one of the most widely used animal models.
Physiological functions of corticosteroid hormones involve activation of intracellular receptors as well as poorly understood membrane receptors. HC is believed to diffuse freely across the cellular membrane to be linked to a cytosol receptor.12 In the past, some neurophysiological results suggested that corticosteroids could act nongenomically and specifically through their membrane receptor on a neuronal surface.13 The presence of a nuclear corticosteroid receptor has been recently demonstrated in the RPE.14 However, no membrane receptor for corticosteroids, which could explain the exclusive response to apical stimulation, has yet been identified.
Although the exact cellular mechanisms of HC in the RPE remain to be determined, the present study provides evidence for chloride/bicarbonate dependency of the response induced by HC. Both Cl- and HCO3- have previously been linked to transepithelial fluid transport in bovine RPE.15 However, there was no evidence for the implication of NaK2Cl cotransport in this chloride mediated response, as it remained unchanged by pretreatment with apical bumetanide.
In previously published data on bovine RPE, an increase of the PD has been linked to apical epinephrine stimulation, enhancing apical to basal chloride flux and transepithelial fluid transport, which were both inhibited by pretreatment with apical bumetanide.16 The effect of epinephrine is known to implicate intracellular Ca++ as a second messenger.17
The opposite effect has been associated with increased intracellular cyclic adenosine monophosphate (cAMP), inhibiting fluid absorption in bullfrog RPE18 and basolateral membrane chloride conductance in chick RPE.19 Intracellular cAMP might not be directly implicated as a second messenger in the response observed with HC in the present study, but there is some evidence for synergistic cellular effects between cAMP and corticosteroid mediated mechanisms20 that remain to be demonstrated in RPE cells.
| Acknowledgements |
|---|
| Footnotes |
|---|
Submitted for publication April 7, 2000; revised September 7, 2000; accepted September 15, 2000.
Commercial relationships policy: N.
Presented at the annual meeting of the Association for Research in Vision and Ophthalmology, Fort Lauderdale, Florida, May, 1999.
Corresponding author: Carl-Friedrich Arndt, Exploration Fonctionnelle de la Vision, Hôpital Roger Salengro, 2 avenue Oscar Lambret, F-59037 Lille cedex, France. carndt{at}univ-lille2.fr
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
D. M. Gamm, J. N. Melvan, R. L. Shearer, I. Pinilla, G. Sabat, C. N. Svendsen, and L. S. Wright A Novel Serum-Free Method for Culturing Human Prenatal Retinal Pigment Epithelial Cells Invest. Ophthalmol. Vis. Sci., February 1, 2008; 49(2): 788 - 799. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Pitkanen, V.-P. Ranta, H. Moilanen, and A. Urtti Permeability of Retinal Pigment Epithelium: Effects of Permeant Molecular Weight and Lipophilicity Invest. Ophthalmol. Vis. Sci., February 1, 2005; 46(2): 641 - 646. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |